Evaluating Clinical Trial Data for Deucravacitinib in Plaque Psoriasis
Linda Stein Gold, MD, and Bruce Strober, MD, PhD, explore the phase 3 data for deucravacitinib, as well as the dosage, and lack of drug-drug interactions associated with it.
Read More
Traditional Steroids vs Emerging Therapies in Atopic Dermatitis
Alexandra Golant, MD, comments on the adverse events of systemic therapies and how emerging nonsteroidal agents have a better safety profile in atopic dermatitis.
Treatment Landscape in Atopic Dermatitis
Matthew Zirwas, MD, highlights therapies that are available for the treatment of atopic dermatitis, including corticosteroids, calcineurin inhibitors and JAK inhibitors.
The Impact of Atopic Dermatitis on Quality of Life
Expert dermatologists review the impact of atopic dermatitis on quality of life for both the patient and their families.
An Overview of Atopic Dermatitis (AD)
Peter A. Lio, MD, provides an overview of the pathophysiology of atopic dermatitis (AD) and the comorbidities often associated with it.
Understanding the Differences Between Inhibiting TYK2 Versus Traditional JAK Inhibition
Thought leaders talk about the approval and integration of a first-in-class agent into the treatment armamentarium. They also review the mechanisms of TYK2 inhibition.
Psoriasis Treatment Landscape Overview and Assessment of Efficacy
Linda Stein Gold, MD, and Bruce Strober, MD, PhD, assess the efficacy of traditional and newer treatment options for psoriasis. They also discuss therapeutic targets and the goals of therapy.
Future Directions for Atopic Dermatitis Management
Raj J. Chovatiya, MD, PhD; Alexandra K. Golant, MD; Eric Simpson, MD, MCR; and Linda Stein Gold, MD, share clinical pearls and discuss the future treatment landscape for atopic dermatitis.
Patient Challenges With Available Therapies for Atopic Dermatitis
Alexandra K. Golant, MD; Raj J. Chovatiya, MD, PhD; and Eric Simpson, MD, MCR, discuss challenges adolescent and adult patients face with current oral and topical therapies and optimizing disease management.
JAK Inhibitors in Clinical Practice for Atopic Dermatitis Treatment
Experts in the management of atopic dermatitis assess the use of JAK inhibitors in clinical practice and considerations for treatment selection for patients with atopic dermatitis.
Using Topical Versus Oral JAK Inhibitors in Atopic Dermatitis
Alexandra K. Golant, MD; Raj J. Chovatiya, MD, PhD; and Eric Simpson, MD, MCR, share their approach to prescribing decisions for oral and topical JAK inhibitors for patients with atopic dermatitis.
Addressing JAK Inhibitor Boxed Warnings in Atopic Dermatitis
Drs Alexandra K. Golant, Raj J. Chovatiya, Linda Stein Gold, and Eric Simpson comment on clinical implications of boxed warnings for the utilization of JAK inhibitors when treating atopic dermatitis.
JAK Inhibitor Therapies for Atopic Dermatitis
Eric Simpson, MD, MCR, leads a discussion on current FDA approved topical and systemic JAK inhibitors for the management of atopic dermatitis.
Patient Selection of JAK Inhibitors in Atopic Dermatitis
Alexandra K. Golant, MD, highlights factors to consider when recommending the use of JAK inhibitors to manage atopic dermatitis for various patient populations.
Role of JAK Inhibitors for Atopic Dermatitis Treatment
Raj J. Chovatiya, MD, PhD, provides an overview of JAK inhibitors and their use in atopic dermatitis treatment.
Treatment Goals and Challenges for Atopic Dermatitis Management
Alexandra K. Golant, MD; Raj. Chovatiya, MD, PhD; and Eric Simpson, MD, MCR, discuss goals of therapy for patients with atopic dermatitis and challenges physicians face in management of the disease.
Conventional Treatment Options for Atopic Dermatitis
Eric Simpson, MD, MCR, reviews conventional topical and systemic therapy treatment options for the management of atopic dermatitis.
Approaching Treatment of Atopic Dermatitis
Drs Eric Simpson, Alexandra K. Golant, and Raj J. Chovatiya share their approaches to atopic dermatitis care.
Burden of Atopic Dermatitis
Raj J. Chovatiya, MD, PhD, comments on the impact of atopic dermatitis on the quality of life for patients and their families.